Mr. Speaker, we are here today to discuss the victims of thalidomide. It is not a time for partisan sniping.
If I might just address the member's question, we have always looked at evidence during our committee hearings and every recommendation that we have ever brought forward was evidence-based. Under Vanessa's law, a new era of transparency has come in with our drug safety approvals. We are now posting clinical trial information online, and the Minister of Health will now have the ability to compel drug companies to remove unsafe drugs from shelves, instead of simply negotiating.
I would like to ensure that the debate today reverts to the victims of thalidomide, instead of this type of partisanship.